1/76
Looks like no tags are added yet.
Descriptive/Theoretical Sciences
Sciences that describe and explain how nature IS (e.g., the Human Genome Project mapping DNA); raise few ethical questions
Engineering Sciences
Sciences that use knowledge to CHANGE or build things (e.g., CRISPR editing DNA); raise the ethical question 'SHOULD we?'
Human Genome Project (HGP)
Project started in 1990 by a team of scientists to identify and map all ~25,000 genes in the human genome
When did the HGP start and finish?
Started 1990; took 13 years; finished April 14, 2003
Coding DNA vs. 'Junk' DNA
Coding DNA contains genes that make proteins; 'junk' (non-coding) DNA does not code for proteins
How long does DNA sequencing take today?
Approx. 1 day; the record is 5 hours & 2 minutes
Why map the genome / sequence DNA?
Provides baseline knowledge allowing doctors & scientists to identify gene variants responsible for disease (e.g., ALS, cystic fibrosis, cancer)
Who might have a genetic disease?
Possibly anyone; higher risk for individuals with a family history of a disease and certain racial or ethnic groups
Pre-implantation Genetic Diagnosis (PGD)
Used in IVF; genomes of embryos are screened and only 'healthy' embryos are inserted into the uterus, in the hope they implant in the uterine wall
Prenatal Genetic Screening
Testing a fetus for genetic disorders after conception; traditionally done with amniocentesis
Amniocentesis
Traditional prenatal test done after conception has occurred; samples the fluid around the fetus to test for genetic disorders
NIPT (Non-Invasive Prenatal Testing)
Newer prenatal test that reads fetal DNA from a blood sample of the mother
Genetic Screening vs. Full Genome Mapping
Genetic screening looks for specific genes; full genome mapping sequences the entire genome
Late-Onset Genetic Disease
A genetic disease that appears later in life (e.g., Huntington's in middle age)
'Burden of Knowing'
The psychological weight of learning you carry a gene for a disease (especially late-onset or incurable) — would you want to know?
Phenotype
The observable traits of an organism; shaped by genes + environment/lifestyle and genes interacting with other genes
Deterministic Genes
Having the gene means you WILL get the disease (e.g., Huntington's)
Probabilistic Genes
The gene RAISES your risk but doesn't guarantee the disease (e.g., BRCA1/BRCA2)
Actionable Genes
Genes where test results let you actually do something to prevent or treat the disease (e.g., BRCA1/BRCA2)
BRCA1 & BRCA2
Genes often associated with breast & ovarian cancer; per class notes, women who test positive have an 85% chance of breast cancer and 50% chance of ovarian cancer
Angelina Jolie Case
Tested BRCA1-positive; had a preventive double mastectomy (2013) and ovaries removed (2015); example of actionable genes and the 'burden of knowing'
'Angelina Effect'
The surge in BRCA genetic testing after Angelina Jolie went public with her results
Psychosocial Risks of Genetic Testing
Anxiety, family conflict, guilt, and possible job or insurance discrimination against someone known to have certain genes
Affordable Care Act (Obamacare)
Law that prevents health insurers from denying coverage for pre-existing conditions
GINA (2008)
Genetic Information Nondiscrimination Act; bans genetic discrimination in health insurance and employment, but NOT life, disability, or long-term care insurance
CRISPR Technology
A way of editing DNA by introducing Cas9 proteins & guide RNAs into a cell; an organism's genome can be 'cut' & 'altered' at any desired location
Two Components of CRISPR
Cas9 and guide RNA
Cas9
The 'scissors' protein in CRISPR that cuts the DNA
Guide RNA
The 'GPS' in CRISPR that leads Cas9 to the exact spot in the DNA
Origin of CRISPR
Comes from a natural bacterial immune system
Who won the Nobel Prize for CRISPR?
Jennifer Doudna & Emmanuelle Charpentier (2020)
Off-Target Effects
A CRISPR risk where the wrong spot in the DNA gets cut/edited
Mosaicism
A CRISPR risk where only some cells get edited, leaving a mix of edited and unedited cells
Germ Cells
Reproductive cells (sperm and eggs)
Germline Therapy
Doctors change the DNA of sperm/eggs/embryos; changes are inherited by all future generations; currently under a moratorium
Benefit of Germline Therapy
All future generations would be free of that genetic defect
Key Question of Germline Therapy
When would this therapy be appropriate?
Moratorium
A temporary ban/pause; germline editing is under a widely supported moratorium
Somatic Cell Therapy
Doctors insert 'good' genes into body cells (e.g., bone marrow) hoping to replace 'bad' genes; affects ONLY the patient, not inherited
Casgevy
CRISPR-based, cell-based gene therapy for sickle cell disease and beta thalassemia; edits the patient's own blood stem cells to turn fetal hemoglobin back on; approved UK Nov 2023, US Dec 2023
In Vitro
Latin for 'in glass'; done outside a living body, in a lab dish or test tube
In Vivo
Latin for 'in the living'; done inside a living body
Ex Vivo
Latin for 'out of the living'; cells are taken out of the body, edited in a lab, then put back (e.g., Casgevy)
In-Vitro Fertilization (IVF)
Egg and sperm are combined in a lab dish, then the embryo is placed in the uterus
Normal Inheritance
A gene has a 50% chance of being passed to offspring
Gene Drive
A CRISPR 'copy-paste' system that copies itself onto the partner chromosome so nearly 100% of offspring inherit it; spreads a trait through an entire wild population in a few generations
Uses of Gene Drives
Malaria (make Anopheles mosquitoes infertile or unable to carry the parasite), invasive species (e.g., rats/mice on islands), Lyme disease (e.g., making mice resistant)
Target Malaria
Project working to use gene drive mosquitoes to fight malaria in Africa
Ethical Concerns of Gene Drives
May be irreversible; ecosystem effects; crosses borders (who decides?); consent of affected communities; possible misuse as a weapon
Germline Editing vs. Gene Drive
Germline editing changes ONE family line; a gene drive changes an ENTIRE species
Reversal Drive
A second gene drive released to undo or overwrite a first gene drive that has already spread; the 'undo button'
How a Reversal Drive Works
Spreads the same way (nearly 100% inheritance), targets the original drive, cuts it out or disables it, and can restore the original gene
Immunizing Reversal Drive
A reversal drive that also makes the organism resistant to the original drive so it can't spread back
Who proposed reversal drives?
Kevin Esvelt and colleagues (2014), as a safety backup for gene drives
Limitations of Reversal Drives
Can't undo ecological damage already done; leaves some CRISPR DNA behind; requires releasing another engineered organism; mostly tested only in lab insects
He Jiankui
Chinese scientist who in 2018 used CRISPR on embryos during IVF to edit the CCR5 gene to make babies resistant to HIV
'Lulu' and 'Nana'
The twin girls born in 2018 from He Jiankui's CRISPR germline editing; a third baby was born in 2019
CCR5 Gene
The gene He Jiankui edited; HIV uses it to enter cells, so disabling it can give HIV resistance
Where/when did He Jiankui announce his work?
November 2018 at a gene-editing summit in Hong Kong
He Jiankui's Punishment
Sentenced in 2019 to 3 years in prison plus a fine; released in 2022
Ethical Problems with He Jiankui's Experiment
Germline edit (inherited); not medically necessary (sperm washing already prevents HIV transmission); consent problems; off-target effects & mosaicism; secrecy/no oversight; enhancement vs. therapy
Impact of He Jiankui Case
Led to stronger calls for a global moratorium on germline editing
Victoria Gray
Mississippi woman who in 2019 became the first U.S. patient treated with CRISPR for sickle cell disease; her severe pain crises stopped; led to Casgevy
Ethics of Victoria Gray Case
Somatic edit (not inherited) so widely accepted; but treatment costs $2 million+, raising justice/access issues
Baby KJ Muldoon (2025)
Infant at Children's Hospital of Philadelphia with CPS1 deficiency; first patient to receive a personalized CRISPR (base editing) treatment delivered in vivo
Ethics of Baby KJ Case
Infant can't consent (parents decided); experimental risk vs. likely fatal disease; who pays for custom treatments?
Jesse Gelsinger (1999)
18-year-old who died in a University of Pennsylvania gene therapy trial from an immune reaction to the virus used to deliver the gene
Ethics of Jesse Gelsinger Case
Risks not fully disclosed and financial conflicts of interest; led to stricter informed consent rules and set gene therapy back for years
Kyrou et al. (2018)
Imperial College London study that released a gene drive targeting the doublesex gene into caged malaria mosquitoes; the population completely collapsed in ~7-11 generations
Ethics of Kyrou Mosquito Study
Malaria kills hundreds of thousands yearly, mostly children in Africa; but a wild release could wipe out a species; who decides (local communities vs. scientists)?
Motivation Shift in Sports Enhancement
Primary motivation shifts toward personal image, muscle building, and body dysmorphia rather than competitive performance
Trickle-Down Effect
Enhancement use by pros influences amateurs and kids; an autonomy and public health concern
Therapy vs. Enhancement
Therapy restores normal function; enhancement improves beyond normal
Therapeutic-Use Exemptions (TUEs)
Allow athletes to use banned substances if medically needed
Physiologic Dose
A dose that restores normal levels (therapy); going above normal (supraphysiologic) is enhancement
Purpose/Telos of Sport
Possible purposes: entertainment, money-generation, self-overcoming/discovery, testing human limitations, fun
Gene Doping
Using gene editing to enhance athletic performance